Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study

By Coppola G.   Caliendo G.   Veggiotti P.   Romeo A.   Tortorella G.   De Marco P.   Pascotto A.  

Epilepsy Research, Vol. 51, Iss. 1, 2002-09 ,pp. : 147-153

Elsevier

Access to resources Recommend Favorite

Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome

By Aldenkamp A.P.   Majoie H.J.M.   Berfelo M.W.   Evers S.M.A.A.   Kessels A.G.H.   Renier W.O.   Wilmink J.  

Epilepsy & Behavior, Vol. 3, Iss. 5, 2002-10 ,pp. : 475-479

Elsevier

Access to resources Recommend Favorite

Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis

By Kaminska A.   Ickowicz A.   Plouin P.   Bru M.F.   Dellatolas G.   Dulac O.  

Epilepsy Research, Vol. 36, Iss. 1, 1999-08 ,pp. : 15-29

Elsevier

Access to resources Recommend Favorite

Sleep in Lennox-Gastaut syndrome: the role oft the cyclic alternating pattern (CAP) in the gate control of clinical seizures and generalized polyspikes

By Eisensehr I.   Parrino L.   Noachtar S.   Smerieri A.   Terzano M.G.  

Epilepsy Research, Vol. 46, Iss. 3, 2001-09 ,pp. : 241-250

Elsevier

Access to resources Recommend Favorite

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy

By Ben-Menachem E.   Edrich P.   Van Vleymen B.   Sander J.W.A.S.   Schmidt B.  

Epilepsy Research, Vol. 53, Iss. 1, 2003-02 ,pp. : 57-64

Elsevier

Access to resources Recommend Favorite